Health In Tech Shareholders Approve 720M Authorized Shares and Yorkville Over-20% Issuance
HIT is trading near its 52-week low of $0.492 (12% above the low) on light trading volume (0.4× avg).
Summary
At the November 10 annual meeting, Health In Tech shareholders approved tripling authorized shares to 720 million, the over-20% Yorkville issuance, and a tripled equity-plan reserve. The approvals unlock the financing capacity the company needs but clear the way for substantial dilution.
Key Events · Corporate Governance and Compliance · HIT
-
Authorized Shares Tripled to 720M
Stockholders approved amending the charter to raise authorized capital from 220,000,000 to 720,000,000 shares: 650,000,000 Class A, 50,000,000 Class B and 20,000,000 Series A Preferred.
-
Yorkville Over-20% Issuance Cleared
Holders approved issuing more than 20% of outstanding Class A stock under the August 12, 2026 Standby Equity Purchase Agreement with YA II PN, Ltd., including shares on conversion of the convertible notes.
-
Equity Plan Reserve Tripled
The 2024 Equity Incentive Plan reserve rose from 10,677,849 to 30,677,849 Class A shares, with the aggregate incentive stock option limit set at 13,000,000 shares.
-
Board and Auditor Confirmed
All five nominees were elected, including new director Tim Cortes, and MaloneBailey, LLP was ratified as independent auditor for fiscal 2026.
Analysis · HIT · Finance
Two constraints that had been blocking the company's financing path are now cleared: authorized capital rises from 220 million to 720 million shares, and holders signed off on issuing more than 20% of the Class A float under the Yorkville standby equity agreement. That headroom is what keeps the Yorkville facility usable against a $1.6 million quarterly net loss and negative operating cash flow — but it also means the dilution already registered for resale can now actually be issued. The equity plan reserve was also tripled to 30.7 million shares, adding further future issuance. Tim Cortes, the new director, joins a board that received Nasdaq deficiency letters in October over independent-director and audit-committee composition.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.55 on NASDAQ in the Finance sector, with a market capitalization of approximately $36.5M. The 52-week trading range was $0.49 to $2.85. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.